Air Methods Corp. Flies to American Securities
Air Methods Corporation (NASDAQ: AIRM), a global air medical transportation company, has been on the acquisition trail since the late 1990s, announcing 12 deals targeting smaller air ambulance operators. Now it’s a takeover target itself, thanks to activist shareholder Voce Capital Management LLC. Voce Capital, and its managing director J. Daniel Plants, had been calling for Air Methods management to put the company on the block as far back as 2015. In February 2017, the investment firm launched a fight for four board seats and publicly criticized AIRM’s financial returns and “a multi-year syndrome of operational, strategic and governance failures.” Air Methods... Read More »PE Firms Flock to Dermatology Deals
Dermatology practices remain high on the list of healthcare sectors for private equity investors. Through mid-March, 2017, 12 deals targeting these practices have been announced by eight acquirers. All those acquirers are either private equity firms, or portfolio companies. Thanks to the private nature of these transactions, no financial terms have been publicly disclosed. Of the 17 dermatology deals announced in 2016, six acquirers were private equity firms and five were portfolio companies. Some big deals (even without disclosing prices) announced last year include Harvest Partners’ acquisition of Advanced Dermatology and Cosmetic Surgery from Audax Group, in May... Read More »Allergan Inks its Third Deal of the Year
As of mid-March, Allergan (NYSE: AGN) has spent nearly $4 billion on three acquisitions in 2017. Although its $2.48 billion purchase of ZELTIQ® Aesthetics, Inc. accounts for most of that total, the pharmaceutical giant hasn’t failed to strengthen its several pipelines in the meantime. On January 9, 2017, it purchased global rights to Assembly Biosciences’ (NASDAQ: ASMB) preclinical compounds for $50 million upfront. The compounds include ABI-M201 and ABI-M301, for ulcerative colitis (UC) and Crohn’s disease (CD), as well as two additional compounds to be identified by Assembly for irritable bowel syndrome (IBS). Then, on March 14, Allergan entered a strategic research and development... Read More »Behavioral Health Care Posts 30% Increase in Deal Volume
The Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008, which was originally independent from the Affordable Care Act (ACA), requires health insurers and group plans that already offer mental illness coverage to provide the same level of benefits as they would for medical and surgical care. Beginning in 2014, the ACA extended the reach of the MHPAEA by requiring all qualified health plans offered through the health insurance marketplaces to include coverage for mental and addiction disorders as one of the 10 categories of Essential Health Benefits. It also states that the coverage must comply with the federal parity requirements set forth in the MHPAEA. The uncertainty... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
